These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 1893503

  • 1. Leprosy control through multidrug therapy (MDT).
    Noordeen SK.
    Bull World Health Organ; 1991; 69(3):263-9. PubMed ID: 1893503
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Global review of multidrug therapy (MDT) in leprosy.
    Noordeen SK, Lopez Bravo L, Daumerie D.
    World Health Stat Q; 1991; 44(1):2-15. PubMed ID: 2068821
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Leprosy control in Zambia.
    Steenbergen GJ.
    World Health Stat Q; 1991; 44(1):30-5. PubMed ID: 2068823
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 25 years of MDT: a caveat.
    Soutar D.
    Lepr Rev; 2004 Dec; 75(4):406. PubMed ID: 15682979
    [No Abstract] [Full Text] [Related]

  • 10. [Leprosy control and multidrug therapy in Togo: problems and perspectives].
    Edorh AA, Tignokpa N, David MT, Ihou E.
    Acta Leprol; 1992 Dec; 8(1):23-8. PubMed ID: 1523962
    [Abstract] [Full Text] [Related]

  • 11. Multidrug therapy--the pathway for global leprosy elimination.
    al-Qubati Y, al-Kubati AS.
    Indian J Lepr; 2000 Dec; 72(4):477-90. PubMed ID: 11212482
    [Abstract] [Full Text] [Related]

  • 12. Operational barriers to the implementation of multidrug therapy and leprosy elimination in Cameroon.
    Nsagha DS, Bamgboye EA, Oyediran AB.
    Indian J Dermatol Venereol Leprol; 2009 Dec; 75(5):469-75. PubMed ID: 19736425
    [Abstract] [Full Text] [Related]

  • 13. Eliminating leprosy as a public health problem--is the optimism justified?
    Noordeen SK, Roxas MG, Fine PE, Smith WC, Feenstra P, Gokhale SD, Joo LK, Huan-Ying L, Khalafalla G, Becx-Bleumink M, Srinivasan H, Rao CK, Lechat MF, Sansarricq H.
    World Health Forum; 1996 Dec; 17(2):109-44. PubMed ID: 8936264
    [Abstract] [Full Text] [Related]

  • 14. The final push to eliminate leprosy.
    Neira MP.
    Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2 Suppl):S7-9. PubMed ID: 11757179
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Antileprosy polychemotherapy in the member states of the OCCGE: a decade of implementation (1983-19930). The National Coordinators of the Leprosy Program of the 8 states of the OCCGE].
    Tiendrebeogo A, Blanc L, Sylla PM.
    Acta Leprol; 1995 Jun; 9(3):139-47. PubMed ID: 7631585
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.